参考文献/References:
[1] Silvestre OM,Gon?alves A,Nadruz W Jr,et al. Ferritin levels and risk of heart failure —the Atherosclerosis Risk in Communities Study[J]. Eur J Heart Fail,2017,19(3):340-347.
[2] 邓英建,郑小燕,涂涛,等. 铁超负荷性心肌病一例[J]. 中华心血管病杂志,2018,46(3):225-227.
[3] Beattie JM,Khatib R,Phillips CJ,et al. Iron deficiency in 78 805 people admitted with heart failure across England:a retrospective cohort study[J]. Open Heart,2020,7(1):e001153.
[4] Zusman O,Itzhaki Ben Zadok O,Gafter-Gvili A. Management of iron deficiency in heart failure[J]. Acta Haematol,2019,142(1):51-56.
[5] 中国医师协会心力衰竭专业委员会,国家心血管病专家委员会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编辑委员会. 中国心力衰竭患者离子管理专家共识[J]. 中华心力衰竭和心肌病杂志,2020,4(1):16-31.
[6] Mordi IR,Tee A,Lang CC. Iron therapy in heart failure:ready for primetime?[J]. Card Fail Rev,2018,4(1):28-32.
[7] Lam CSP,Doehner W,Comin-Colet J,et al. Iron deficiency in chronic heart failure:case-based practical guidance[J]. ESC Heart Fail,2018,5(5):764-771.
[8] Kobak KA,Radwańska M,Dzi?ga?a M,et al. Structural and functional abnormalities in iron-depleted heart[J].?Heart Fail Rev,2019,24(2):269-277.
[9] Dong F,Zhang X,Culver B,et al. Dietary iron deficiency induces ventricular dilation,mitochondrial ultrastructural aberrations and cytochrome c release:involvement of nitric oxide synthase and protein tyrosine nitration[J]. Clin Sci (Lond),2005,109(3):277-286.
[10] Chung YJ,Swietach P,Curtis MK,et al. Iron-deficiency anemia results in transcriptional and metabolic remodeling in the heart toward a glycolytic phenotype[J]. Front Cardiovasc Med,2021,7:616920.
[11] Hoes MF,Grote Beverborg N,Kijlstra JD,et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function[J].Eur J Heart Fail,2018,20(5):910-919.
[12] Haddad S,Wang Y,Galy B,et al. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure[J]. Eur Heart J,2017,38(5):362-372.
[13] Ponikowski P,v an Veldhuisen DJ,Comin-Colet J,et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency dagger[J]. Eur Heart J,2015,36(11):657-668.
[14] Klip IT,Voors AA,Swinkels DW,et al. Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community[J]. Eur J Heart Fail,2017,19(3):348-356.
[15] Anand IS,Gupta P. Anemia and iron deficiency in heart failure:current concepts and emerging therapies[J].?Circulation,2018,138(1):80-98.
[16] Lewis GD,Malhotra R,Hernandez AF,et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency:the IRONOUT HF randomized clinical trial[J]. JAMA,2017, 317(19):1958-1966.
[17] Liu B,Zhao C,Li H,et al. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis[J].?Biochem Biophys Res Commun,2018,497(1):233-240.
[18] Girelli D,Nemeth E,Swinkels DW. Hepcidin in diagnosis of iron disorders[J]. Blood,2016,127(23):2809-2813.
[19] Hentze MW,Muckenthaler MU,Galy B,et al. Two to tango:regulation of mammalian iron metabolism[J]. Cell,2010,142(1):24-38.
[20] Solomakhina NI,Nakhodnova ES,Gitel EP,et al. Hepcidin and its relationship with inflammation in old and older patients with anemia of chronic disease associated with CHF[J]. Kardiologiia,2018(S2):4-11.
[21] Kanamori Y,Murakami M,Sugiyama M,et al. Interleukin-1β(IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes[J].?J Biol Chem,2017,292(24):10275-10287.
[22] Kanamori Y,Murakami M,Matsui T,et al. JNK facilitates IL-1β-induced hepcidin transcription via JunB activation[J].?Cytokine,2018,111:295-302.
[23] Stockwell BR,Friedmann Angeli JP,Bayir H,et al. Ferroptosis:a regulated cell death nexus linking metabolism,redox biology,and disease[J]. Cell,2017,171(2):273-285.
[24] Dixon SJ,Lemberg KM,Lamprecht MR,et al. Ferroptosis:an iron-dependent form of nonapoptotic cell death[J].?Cell,2012,149(5):1060-1072.
[25] Yang WS,Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent,nonapoptotic cell death in oncogenic-RAS-harboring cancer cells[J]. Chem Biol,2008,15(3):234-245.
[26] Valko M,Jomova K,Rhodes CJ,et al. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease[J].?Arch Toxicol,2016,90(1):1-37.
[27] Wang J,Deng B,Liu Q,et al. Pyroptosis and ferroptosis induced by mixed lineage kinase 3(MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload[J].?Cell Death Dis,2020,11(7):574.
[28] 季春影,张瑞英. 心力衰竭与心肌线粒体代谢[J]. 心血管病学进展,2020,41(1):63-66.
[29] Gao M,Yi J,Zhu J,et al. Role of mitochondria in ferroptosis[J].?Mol Cell,2019,73(2):354-363.
[30] Qi Z,Chen L. Endoplasmic reticulum stress and autophagy[J].?Adv Exp Med Biol,2019,1206:167-177.
[31] So JS. Roles of endoplasmic reticulum stress in immune responses[J].?Mol Cells,2018,41(8):705-716.
[32] Wang X,Xu L,Gillette TG,et al. The unfolded protein response in ischemic heart disease[J].?J Mol Cell Cardiol,2018,117:19-25.
[33] Binder P,Wang S,Radu M,et al. Pak2 as a novel therapeutic target for cardioprotective endoplasmic reticulum stress response[J].?Circ Res ,2019,124(5):696-711.
[34] Li W,Li W,Leng Y,et al. Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress[J].?DNA Cell Biol,2020,39(2):210-225.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(1):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(1):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(1):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(1):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(1):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(1):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[11]王文杰 杨嘉馨 丁耀东 王可馨 牛佳龙 葛海龙.铁死亡在心血管疾病中的研究进展[J].心血管病学进展,2023,(5):420.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.009]
WANG Wenjie,YANG Jiaxin,DING Yaodong,et al.Ferroptosis in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(1):420.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.009]